Context Therapeutics
Stock Forecast, Prediction & Price Target

Context Therapeutics Financial Estimates

Context Therapeutics Revenue Estimates

Context Therapeutics EBITDA Estimates

Context Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $8.8M
Low: $8.8M
High: $8.8M
avg. 0%
Net Income
 
% change YoY
$-7.43M
 
N/A
$-14.29M
 
-92.25%
$-23.96M
 
-67.69%
Avg: $-24.13M
Low: $-5.90M
High: $-4.47M
avg. -0.72%
Avg: $-33.76M
Low: $-7.82M
High: $-6.86M
avg. -39.88%
Avg: $-9.73M
Low: $-9.73M
High: $-9.73M
avg. 71.15%
Avg: $-12.29M
Low: $-12.29M
High: $-12.29M
avg. -26.22%
EBITDA
 
% change YoY
$-7.31M
 
N/A
$-14.37M
 
-96.49%
$-25.06M
 
-74.37%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.47
 
N/A
-$0.9
 
-91.48%
-$1.5
 
-66.66%
Avg: -$0.34
Low: -$0.37
High: -$0.28
avg. 77.33%
Avg: -$0.47
Low: -$0.49
High: -$0.43
avg. -38.23%
Avg: -$0.61
Low: -$0.61
High: -$0.61
avg. -29.78%
Avg: -$0.77
Low: -$0.77
High: -$0.77
avg. -26.22%
Operating Expenses
 
% change YoY
$7.43M
 
N/A
$14.88M
 
100.07%
$25.07M
 
68.48%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Context Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 1.07% in 2025-2028.

We have gathered data from 2 analysts. Their low estimate is -5.90M, average is -24.13M and high is -4.47M.

What is Context Therapeutics stock revenue growth forecast?

We have gathered data from 3 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Context Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -4.22% in 2025-2028.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.37, average is -$0.34 and high is $-0.28.

What is the best performing analyst?

In the last twelve months analysts have been covering Context Therapeutics stock. The most successful analyst is Joseph Catanzaro.